AAAAAA

   
Results: 1-11 |
Results: 11
SAFETY AND TOLERABILITY OF SUBCUTANEOUS CLADRIBINE THERAPY IN PROGRESSIVE MULTIPLE-SCLEROSIS
Authors: SELBY R BRANDWEIN J OCONNOR P
Citation: R. Selby et al., SAFETY AND TOLERABILITY OF SUBCUTANEOUS CLADRIBINE THERAPY IN PROGRESSIVE MULTIPLE-SCLEROSIS, Canadian journal of neurological sciences, 25(4), 1998, pp. 295-299
LOW INCIDENCE OF MYELODYSPLASIA (MDS) OR ACUTE-LEUKEMIA (AML) AFTER AUTOLOGOUS BLOOD OR MARROW TRANSPLANT WITHOUT TOTAL-BODY RADIATION (TBI) FOR LYMPHOMA
Authors: CRUMP M ALHOMAIDHI A IMRIE K STEWART AK BRANDWEIN J KEATING A
Citation: M. Crump et al., LOW INCIDENCE OF MYELODYSPLASIA (MDS) OR ACUTE-LEUKEMIA (AML) AFTER AUTOLOGOUS BLOOD OR MARROW TRANSPLANT WITHOUT TOTAL-BODY RADIATION (TBI) FOR LYMPHOMA, European journal of cancer, 33, 1997, pp. 406-406
SALVAGE CHEMOTHERAPY WITH MINI-BEAM FOR RELAPSED OR REFRACTORY NON-HODGKINS-LYMPHOMA PRIOR TO AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: GIROUARD C DUFRESNE J IMRIE K STEWART AK BRANDWEIN J PRINCE HM PANTOLONY D KEATING A CRUMP M
Citation: C. Girouard et al., SALVAGE CHEMOTHERAPY WITH MINI-BEAM FOR RELAPSED OR REFRACTORY NON-HODGKINS-LYMPHOMA PRIOR TO AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Annals of oncology, 8(7), 1997, pp. 675-680
LOW INCIDENCE OF MYELODYSPLASIA OR ACUTE-LEUKEMIA AFTER AUTOLOGOUS BLOOD AND MARROW TRANSPLANT WITHOUT TOTAL-BODY RADIATION FOR LYMPHOMA
Authors: ALHOMAIDHI A CRUMP M IMRIE K STEWART AK BRANDWEIN J SQUIRE J KEATING A
Citation: A. Alhomaidhi et al., LOW INCIDENCE OF MYELODYSPLASIA OR ACUTE-LEUKEMIA AFTER AUTOLOGOUS BLOOD AND MARROW TRANSPLANT WITHOUT TOTAL-BODY RADIATION FOR LYMPHOMA, Experimental hematology, 25(8), 1997, pp. 316-316
SAFETY AND TOLERABILITY OF SUBCUTANEOUS CLADRIBINE THERAPY IN CHRONICPROGRESSIVE MULTIPLE-SCLEROSIS
Authors: OCONNOR PW SELBY R BRANDWEIN J GRAY TA
Citation: Pw. Oconnor et al., SAFETY AND TOLERABILITY OF SUBCUTANEOUS CLADRIBINE THERAPY IN CHRONICPROGRESSIVE MULTIPLE-SCLEROSIS, Neurology, 48(3), 1997, pp. 3071-3071
THE ROLE OF INTENSIVE THERAPY AND AUTOLOGOUS BLOOD AND MARROW TRANSPLANTATION FOR CHEMOTHERAPY-SENSITIVE RELAPSED AND PRIMARY REFRACTORY NON-HODGKINS-LYMPHOMA - IDENTIFICATION OF MAJOR PROGNOSTIC GROUPS
Authors: PRINCE HM IMRIE K CRUMP M STEWART AK GIROUARD C COLWILL R BRANDWEIN J TSANG RW SCOTT JG SUTTON DMC PANTALONY D CARSTAIRS K SUTCLIFFE SB KEATING A
Citation: Hm. Prince et al., THE ROLE OF INTENSIVE THERAPY AND AUTOLOGOUS BLOOD AND MARROW TRANSPLANTATION FOR CHEMOTHERAPY-SENSITIVE RELAPSED AND PRIMARY REFRACTORY NON-HODGKINS-LYMPHOMA - IDENTIFICATION OF MAJOR PROGNOSTIC GROUPS, British Journal of Haematology, 92(4), 1996, pp. 880-889
HIV-ASSOCIATED LYMPHOMA OF THE GASTROINTESTINAL-TRACT - THE UNIVERSITY-OF-TORONTO AIDS-LYMPHOMA STUDY-GROUP EXPERIENCE
Authors: IMRIE KR SAWKA CA KUTAS G BRANDWEIN J WARNER E BURKES R QUIRT I MCGEER A SHEPHERD FA
Citation: Kr. Imrie et al., HIV-ASSOCIATED LYMPHOMA OF THE GASTROINTESTINAL-TRACT - THE UNIVERSITY-OF-TORONTO AIDS-LYMPHOMA STUDY-GROUP EXPERIENCE, Leukemia & lymphoma, 16(3-4), 1995, pp. 343-349
IMMUNE-MEDIATED NEUTROPENIA AND THROMBOCYTOPENIA IN A PATIENT WITH ULCERATIVE-COLITIS - AN UNUSUAL HEMATOLOGICAL ASSOCIATION WITH IBD
Authors: KIM YI BRZEZINSKI A BRANDWEIN J BAKER JP
Citation: Yi. Kim et al., IMMUNE-MEDIATED NEUTROPENIA AND THROMBOCYTOPENIA IN A PATIENT WITH ULCERATIVE-COLITIS - AN UNUSUAL HEMATOLOGICAL ASSOCIATION WITH IBD, Canadian journal of gastroenterology, 9(2), 1995, pp. 96-100
GASTROCOLIC FISTULA SECONDARY TO PRIMARY GASTRIC LYMPHOMA
Authors: OH PIT ZALEV AH COLAPINTO ND DEODHARE SS BRANDWEIN J WARREN RE
Citation: Pit. Oh et al., GASTROCOLIC FISTULA SECONDARY TO PRIMARY GASTRIC LYMPHOMA, Journal of clinical gastroenterology, 20(1), 1995, pp. 45-48
PHASE-I STUDY OF MITOXANTRONE, VINCRISTINE AND DECADRON FOLLOWING REVERSAL OF MULTIDRUG-RESISTANCE BY CYCLOSPORINE-A (C-MOD) IN THE TREATMENT OF CHEMOTHERAPY REFRACTORY MULTIPLE-MYELOMA
Authors: MACKINNON J MEHARCHAND J BRANDWEIN J SUTTON D STEWART AK
Citation: J. Mackinnon et al., PHASE-I STUDY OF MITOXANTRONE, VINCRISTINE AND DECADRON FOLLOWING REVERSAL OF MULTIDRUG-RESISTANCE BY CYCLOSPORINE-A (C-MOD) IN THE TREATMENT OF CHEMOTHERAPY REFRACTORY MULTIPLE-MYELOMA, Blood, 86(10), 1995, pp. 3337-3337
INTERLEUKIN-3 FOLLOWED BY GM-CSF FOR DELAYED ENGRAFTMENT AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: CRUMP M COUTURE F KOVACS M SARAGOSA R MCCRAE J BRANDWEIN J HUEBSCH L BEAUREGARDZOLLINGER L KEATING A
Citation: M. Crump et al., INTERLEUKIN-3 FOLLOWED BY GM-CSF FOR DELAYED ENGRAFTMENT AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Experimental hematology, 21(3), 1993, pp. 405-410
Risultati: 1-11 |